Health Catalyst (HCAT) Q1 2024 Annual Earnings
HCAT·Reported May 9, 2024·After market close
Health Catalyst reported Q1 2024 revenue of $74.7M, missed analyst consensus of $74.8M by $77.0K. Diluted EPS came in at $0.05, beat the $0.03 consensus by $0.02.
Revenue
$74.7Mmissed by $77.0K
Consensus: $74.8MDiluted EPS
$0.05beat by $0.02
Consensus: $0.03
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Health Catalyst's Q1 2024 earnings report.
Health Catalyst (HCAT) reported Q1 2024 earnings on May 9, 2024 after market close.
Health Catalyst reported revenue of $74.7M and diluted EPS of $0.05 for Q1 2024.
Revenue missed the consensus estimate of $74.8M by $77.0K. EPS beat the consensus estimate of $0.03 by $0.02.
You can read the 10-K/A periodic report (0001636422-24-000050) directly on SEC EDGAR. The filing index links above go to sec.gov.